Lv12
30 积分 2026-10-20 加入
2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights
3小时前
待确认
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
3小时前
已完结
The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC
4小时前
已完结
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
4小时前
已完结
皖公网安备34019202002308
